NASDAQ:RARE

Biotechnology·Finance·Investing·NASDAQ:RARE·News

Ultragenyx (RARE) Moves Before Friday’s Bell

Ultragenyx shares rose to $24.06 in premarket trading after Cantor Fitzgerald raised its price target to $96 and increased the probability of success for GTX-102, its Angelman syndrome drug, to 60%. The company expects Phase 3 data for GTX-102 in the second half of 2026 and has two biologics license applications under FDA review.

May 22, 2026

CBA vs Macquarie Shares: Choosing the Best ASX Financial Stock
May 29, 2026, 8:54 PM EDT. Commonwealth Bank of Australia (CBA) and Macquarie Group Ltd (MQG) are two top ASX financial shares with distinct investment profiles. CBA offers stability, scale, and fully franked dividends, benefiting from its dominant position in Australian banking. It appeals to those seeking dependable income and resilience. However, CBA trades at a premium, reflecting its quality. Meanwhile, Macquarie is a global diversified financial group with interests in asset management, infrastructure, commodities, and energy transition. Its earnings are more variable, influenced by market conditions and deal flow, but it offers greater long-term growth potential by adapting to evolving global trends. Investors must weigh CBA's consistent returns against Macquarie's growth flexibility in today's market.